SC 13G
SC 13G Filing
- Company
- MoonLake Immunotherapeutics
- Filed
- March 31, 2023
- Accession Number
- 0000929638-23-001056
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →